Ciclazindol

This classification denotes an antidepressant agent with the molecular formula C17H15ClN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y3I9520J7P, chemically known as 10-(m-chlorophenyl)-2,3,4,10-tetrahydropyrimido(1,2-a)indol-10-ol but generally known as ciclazindol, which bears US NIH Compound Identifier 37825. European Medicines Agency schedules Ciclazindol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06235MIG. The term CICLAZINDOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). CICLAZINDOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ciclazindol under HS 29335995 and SITC 51576. As of Q4 2014, CICLAZINDOL remains the US FDA Preferred Term for this commodity. Ciclazindol bears US NLM identifiers UMLS ID C0055708 and NCI Concept Code C79886. SMILES: Clc1cc(C2(O)C3=NCCCN3c3c2cccc3)ccc1.